Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS‐CoV‐2 infection

Anti‐inflammatory and immune‐modulatory therapies have been proposed for the treatment of COVID‐19 and its most serious complications. Among others, the use of mesenchymal stromal cells (MSCs) is under investigation given their well‐documented anti‐inflammatory and immunomodulatory properties. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Avanzini, Maria A., Mura, Manuela, Percivalle, Elena, Bastaroli, Francesca, Croce, Stefania, Valsecchi, Chiara, Lenta, Elisa, Nykjaer, Giulia, Cassaniti, Irene, Bagnarino, Jessica, Baldanti, Fausto, Zecca, Marco, Comoli, Patrizia, Gnecchi, Massimiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Tissue‐specific Progenitor and Stem Cells
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753681/
https://www.ncbi.nlm.nih.gov/pubmed/33188579
http://dx.doi.org/10.1002/sctm.20-0385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753681/
https://www.ncbi.nlm.nih.gov/pubmed/33188579
http://dx.doi.org/10.1002/sctm.20-0385

Ejemplares similares